Hyundai Bio has newly appeared among the top searched stocks.


As of 2:30 PM on the 9th, Hyundai Bio is trading at 13,000 KRW, down 4.76% from the previous day. This represents a 23.81% increase compared to December 7. Hyundai Bio is known as a manufacturer of bio cosmetics and display products.

Today, foreigners have net purchased 7,000 shares of Hyundai Bio, and institutions have net purchased 10,000 shares, according to provisional data. Over the past five days, individual investors have net sold 31,193 shares, while foreigners and institutions have net bought 34,480 shares and net sold 6,301 shares, respectively.


On December 8, Hyundai Bio became a market issue with the announcement of 'COVID-19 oral treatment preclinical trial results,' causing the stock to rise.




[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing